Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
The Food and Drug Administration on Friday approved the first-ever gene-editing therapy that uses a cutting-edge technology called CRISPR to treat sickle cell disease. Dr. Jon LaPook has more.
View CBS News In
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.